Reumafonds

Wijzig Organisatiedata

Personen

Directie / Management	Drs. H.J.L. Ridderbos

Lopend onderzoek

(het meest recente onderzoek is bovenaan geplaatst)
Financier	Cross-talk between TNF and IFN in rheumatidc arthritis
Financier	Unravelling the molecular pathogenesis of rheumatoid artritis without antibodies against citrullinated peptides using a Genome Wide Association Study
Financier	Modulation of the macrophage inflammatory response in inflammatory arthritis by target delivery of small interfering RNA
Financier	The cholinergic anti-inflammatory pathway: A new target for the treatment of rheumatoid arthritis?
Financier	Identifying the contributions of macrophage Tie2 signalling to pathology in arthritis

Alle lopend onderzoek..

Afgesloten onderzoek

(het meest recente onderzoek is bovenaan geplaatst)
Financier	Why not change the medication in RA? Eliciting rheumatologists’ and patients’ most important reasons to change or not to change treatment
Financier	Towards treatment of Rheumatoid Arthritis by adoptive cellular therapy of regulatory T cells; 'The RA self-treatment program'
Financier	Novel mouse models to study auto-reactive B cells in rheumatic diseases
Financier	The Nijmegen randomised controlled trial on the effectiveness of a multidisciplinary treatment programme in patients with OA of the Hands (NOAH)
Financier	The wnt signaling pathway in osteoarthritis: WISP1, marker or maker of joint pathology?

Alle afgesloten onderzoek..

Classificatie

D23213	Reumatologie
D24200	Preventieve gezondheidszorg, GVO